Quanterix Corporation announced that it has appointed Brian Blaser to its Board of Directors effective as of January 6, 2023. Mr. Blaser brings over 25 years of senior leadership experience in the in-vitro diagnostics industry, including 15 years at Abbott Laboratories where he was responsible for the company's global diagnostics organization, including its core laboratory, point of care, rapid diagnostics, and molecular diagnostics businesses. While at Abbott, he was responsible for the launch of the Alinity family of laboratory instruments and oversaw the acquisition of Alere that made Abbott the global leader in point-of-care and rapid diagnostic testing.

Most recently, Mr. Blaser served as a Senior Advisor to McKinsey and is currently a Director and Chair of the Audit Committee for Rockley Photonics. Over his career, he has held key leadership positions in operations, finance, and engineering with the Ortho Clinical Diagnostics division of Johnson & Johnson, Eastman Kodak, and General Motors. Mr. Blaser received his Master of Business Administration from the Rochester Institute of Technology and his Bachelor of Science in Mechanical Engineering Technology from the University of Dayton.

He currently serves as Chair of the University of Dayton School of Engineering Advisory Council and as Chairman of the Board of Trustees for Cristo-Rey St. Martin College Prep. Mr. Blaser has also served on the Board of Directors for AdvaMed.